Mainframe runs decentralized protein folding and molecular dynamics for pharma compute.
The simplest explanation
Like Folding@home but with financial incentives for accurate simulations.
No jargon. No whitepapers. Just the facts.
Computational biology workloads — protein folding, molecular dynamics, drug-ligand docking — require enormous GPU clusters that smaller biotech companies and academic research groups simply cannot afford. Life science breakthroughs are being delayed because only the biggest pharmaceutical companies can run the simulations.
Mainframe runs decentralized protein folding and molecular dynamics for pharma compute.
Mainframe (by Macrocosmos) is Bittensor's DeSci flagship, supporting OpenMM molecular dynamics, DiffDock protein-ligand docking, and neural network potentials via a production partnership with Rowan Scientific. It has evolved from a single-task protein folding subnet into a generalizable platform for any computational biology workload — accessible to any research team worldwide.
The best way to understand a new technology is to compare it to something familiar.
Mainframe (by Macrocosmos) is Bittensor's DeSci flagship, supporting OpenMM molecular dynamics, DiffDock protein-ligand docking, and neural network potentials via a production partnership with Rowan Scientific. It has evolved from a single-task protein folding subnet into a generalizable platform for any computational biology workload — accessible to any research team worldwide.
Mainframeuses Bittensor's incentive layer to build something no single company could run alone.
Participants (called miners) on the Mainframe subnet compete to produce the best outputs for life sciences compute tasks. Anyone with the right hardware can join.
Validators continuously evaluate miner outputs against objective benchmarks. The best performers rise, the worst are replaced. There's no human committee — the protocol decides.
Miners are paid in the Mainframe alpha token in proportion to how good their work is. This creates a continuous competitive pressure that drives quality up and cost down — structurally, not just as a promise.
Because every participant is aligned toward the same goal — producing the best life sciences compute results — the network improves continuously without requiring a central team to manage it.
Mainframe is Subnet 25 (SN25) on the Bittensor network — a decentralized AI protocol built on the TAO blockchain. Mainframe runs decentralized protein folding and molecular dynamics for pharma compute.
Computational biology workloads — protein folding, molecular dynamics, drug-ligand docking — require enormous GPU clusters that smaller biotech companies and academic research groups simply cannot afford. Life science breakthroughs are being delayed because only the biggest pharmaceutical companies can run the simulations.
Mainframe (by Macrocosmos) is Bittensor's DeSci flagship, supporting OpenMM molecular dynamics, DiffDock protein-ligand docking, and neural network potentials via a production partnership with Rowan Scientific. It has evolved from a single-task protein folding subnet into a generalizable platform for any computational biology workload — accessible to any research team worldwide.
The Mainframe subnet has its own alpha token on Bittensor's dTAO system. It trades in the Bittensor liquidity pool and its price reflects market demand for the subnet's services.
AlphaGap tracks Mainframe using its aGap score — a composite of development activity, token flow, and social signals. This page is for informational purposes only and is not financial advice. Always do your own research before making any investment decisions.
AlphaGap tracks signals, whale flows, developer commits, and the aGap score for every Bittensor subnet — updated continuously. Find the alpha gap before everyone else.
Free preview · Pro from $29/mo · Premium from $49/mo